Sung provides counsel to FDA-regulated companies in developing, distributing, and marketing FDA-regulated digital health products and, when necessary, in responding to regulatory and administrative enforcement actions by federal and state agencies. Sung frequently counsels clients on FDA’s legal and regulatory requirements and policies for digital health products, and provides counsel that allows companies to comply with FDA’s policies and requirements. Sung has experience in responding to FDA’s various enforcement actions such as warning letters, untitled letters, and form 483 notice of inspectional observations. Sung understands the unique business landscape of FDA-regulated products, and provides practical advice that suits the needs of the client’s business.
발표 II : 윤학희 CEO (Harry Yun) / InBody USA
Harry Yun is the CEO of InBody USA, a prominent medical device company from Korea and a worldwide leader in body composition technology with a mission to provide biomedical technology that simplifies the understanding of health and wellness. InBody USA was established in the year 2000 in Beverly Hills, California and has moved its corporate office to Cerritos, California in 2012. Under Yun’s leadership, InBody continues to successfully penetrate the US market with state-of-the-art technology. Yun is a graduate from Hankuk University of Foreign Studies (HUFS) with Masters in Economics and has extensive experience of International Marketing.
발표 III : 조성환 CTO (Sunghwan Cho) / NanoCellect Biomedical Inc
Sunghwan Cho is the CTO of NanoCellect Biomedical Inc, whose mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more affordable and easier to use. He has 15+ years of expertise in integrating microfluidics, optics, micro/nano-fabrication, and electronics for advanced biomedical devices and instruments. He is also an inventor of the company’s core technologies, including its microfluidics-based cell sorting platform, and manages the company’s research project and product development. He was selected as a Marylou Ingram Scholar of the International Society for Advancement of Cytometry (ISAC) from 2012 to 2017, recognized for his contribution to the field of cytometry.
The KSEA proudly announce its 3rd “Science and Technology Entrepreneurship Partners’ Upscale Program (STEP-UP 2022)” which will take place in Edgewater NJ from May 23 to 26, 2022.The STEP-UP aims to promote and enrich the entrepreneurship & partnership activities among KSEA members and other stakeholders. This year’s theme is Healthcare Entrepreneurship, with special emphasis on “Cell & Gene Therapy (CGT)” and “Healthcare in the Digital Era”, both of which are driving paradigm shifts in medicine. The STEP-UP 2022 offers lectures from the experts the field including the introduction of the CGT and Digital Health, US regulations, Laws, Investments, and leading start-ups. The STEP-UP 2022 will feature lectures from industry, academic and government professionals on topics such as the introduction to CGT and Digital Health, US regulatory affairs, legislation, investments, and prominent start-up presentations. We have a leading industry expert, Donghoon Lee, MBA, Executive Vice President, SK Holdings, as a keynote speaker. We are also offering a free group tour to the Cure, a new Biotech-focused incubator in NYC on May 24. We are confident that the event will provide a fantastic opportunity to learn about this emerging sector while also networking with experts. Program details can be found in the attached flyer or our event website. The STEP-UP 2022 will be held as in-person/virtual hybrid format. KSEA encourages you to attend in-person. In-person attendee will receive travel and lodging support.
Date: May 23 – 26, 2022
Venue: Courtyard by Marriott Edgewater NYC Area (3 Pembroke Pl, Edgewater, NJ 07020)
Registration Dates:
Registration opens: April 22, 2022
Early Registration Due: May 09, 2022
In-person registration closed: May 15, 2022
Virtual registration closed: May 21, 2022
Registration Fees:
Regular Registration: $250
Early registration or Entrepreneurship discount: ($100)
KSEA member discount:
Undergraduate/Graduate Students, Postdocs, and YG/YP members: $125 (Supported by -KUSCO)
Regular Members: $100
Virtual only discount: $150 for all members
Support for In-person Attendees (Current KSEA membership and attendance to the sessions are required):
Airfare up to $200 or driving mileage ($0.50/mile) up to $200
Hotel accommodation: Four night (Mon, May 23th ~ Thu, May 26th), Shared room (2 people/room)
Meals: Networking banquet 5/26
Additional support YG/YP participants (additional $100 travel support, networking dinner)
COVID-19 vaccination is required for in-person attendance
For more detailed information, please refer to, stepup.ksea.org.
IL Minn, Ph.D., STEP-UP Chair Brian B. Park, Ph.D., KSEA President Jeho Park, Ph.D., STEP-UP Co-Chair Kevin Kim, STEP-UP Co-Chair Stella Kim, M.S., STEP-UP Co-Chair Kwangrok Kim, M.S., STEP-UP Co-Chair
Pinecone41 is a Fintech startup that specializes in R&D Tax Credit services and provide technology startups accurate and beneficial tax insights that can be used to fuel growth.
Alex is a Tax Partner in KPMG’s Los Angeles Federal Tax Services, Korean practice. Before joining KPMG, Alex started his career in the tax department of Deloitte Korea and performed various tax projects until he was seconded to the US office. He has more than 20 years of experience in U.S. and Korea tax consulting, income tax compliance and income tax provision.
Alex is responsible for a broad range of U.S. multi-national and foreign-owned clients doing business as single entities or joint ventures, and has extensive experience with a wide range of tax matters relating to multi-national businesses. Alex’s current and past clients include leaders in the industrial production industries and high-technology, media, and telecommunication industries.
Alex has provided tax compliance services for various engagements in size from private to multi-national public companies in the U.S. and Korea and has extensive experience in defending corporations against tax examinations by Federal and state tax authorities.
Alex also has provided tax consulting services related to merger & acquisition transactions, business transfer transactions, cross border transactions and various tax due diligence services.
Alex has strong tax technical skills and tax provision skills with extensive experience in ASC 740 and ASC 718-10 for multinational and private companies.
Shawn Kim
Managing Director, KPMG LLP
Sanghoon has over 18 years of experience in dealing with audit, tax and transfer pricing matters for multinationals operating in different industries, from manufacturing and distribution sectors to the financial industry.
Sanghoon manages tax planning, audit defense and documentation projects for significant and complex intercompany transactions, covering tangible goods, complex services, intellectual property and financing structures. He deals with tax authorities on behalf of taxpayers with respect to transfer pricing audit defense and Advance Pricing Arrangements.
Work Experience
• Dealt with tax authorities related to tax audit, tax appeal, advance pricing agreement (APA), and mutual agreement procedure (MAP)
• Assisted companies in preparing worldwide transfer pricing policies
• Assisted companies in preparing FIN 48 analyses
• Prepared transfer pricing planning study and contemporaneous transfer pricing documentations
• Prepared management service fee documentation
• Performed intellectual property valuation analyses
• Performed royalty analysis products, especially in automobile parts industry
***** Notice *****
* Please note that the webinar talk will be presented in ENGLISH language. But Q&A session will be conducted in both English and Korean.
* 이번 세미나는 Maryland 주정부 관계자 분들을 포함하여 영어권 참석자 분들이 있어, 강의는 영어로 진행될 예정입니다. 참고로 질의 응답은 영어와 한국어 모두 가능함을 안내 드립니다.
